The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; SERVIER

A phase II randomized study to compare abemaciclib plus trastuzumab with or without fulvestrant to standard of care chemotherapy plus trastuzumab in hormone receptor positive, HER2-positive advanced breast cancer (monarcHER).
 
Sara M. Tolaney
Research Funding - Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Nawel Bourayou
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Shom Goel
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Research Funding - Lilly
 
Anwar Hossain
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Fabrice Andre
No Relationships to Disclose